MedTrace Logo

Brief Introductory Therapy for Opioid Dependence

NCT00406484 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2020-04-02

No results posted yet for this study

Summary

A randomized clinical trial to compare the efficacy of Behavioral Drug and HIV Risk Reduction Counseling (BDRC) and standard methadone drug counseling.

Conditions

  • Opiate Dependence
  • HIV Infections

Interventions

BEHAVIORAL

Standard drug counseling

Individual drug counseling

BEHAVIORAL

BDRC

Behavioral Drug and HIV Risk Reduction Counseling, individual once or twice weekly sessions

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Marek C Chawarski, Ph.D. · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2009-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00406484 on ClinicalTrials.gov